Cancer and heart failure (HF) are common medical conditions with a steadily rising prevalence in industrialized countries, particularly in the elderly, and they both potentially carry a poor prognosis. A new diagnosis of malignancy in subjects with pre-existing HF is not infrequent, and challenges HF specialists as well as oncologists with complex questions relating to both HF and cancer management. An increased incidence of cancer in patients with established HF has also been suggested. This review paper summarizes the epidemiology and the prognostic implications of cancer occurrence in HF, the impact of pre-existing HF on cancer treatment decisions and the impact of cancer on HF therapeutic options, while providing some practical suggestions regarding patient care and highlighting gaps in knowledge.

• MeSH
• celosvětové zdraví MeSH
• diagnostické zobrazování * MeSH
• incidence MeSH
• komorbidita trendy   MeSH
• lidé MeSH
• management nemoci * MeSH
• míra přežití trendy   MeSH
• nádory * diagnóza   epidemiologie   terapie   MeSH
• prognóza MeSH
• srdeční selhání * diagnóza   epidemiologie   terapie   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• přehledy MeSH